Duffy blood group phenotype-genotype correlations using high-resolution melting analysis PCR and microarray reveal complex cases including a new null FY*A allele: The role for sequencing in genotyping algorithms

Vox Sanguinis

Volumn 109, Issue 3, 2015, Pages 296-303

  Lopez, G H ^a   Morrison, J ^a   Condon, J A ^a   Wilson, B ^a   Martin, J R ^a   Liew, Y W ^a   Flower, R L ^a   Hyland, Catherine A ^a  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

Author keywords

01N.07; Duffy blood group genotyping; Duffy null FY; High resolution melting analysis; RBC antigens and antibodies; Serological testing

Indexed keywords

ANTIBODY; ANTIGEN; BLOOD GROUP DUFFY SYSTEM; CELL SURFACE RECEPTOR; DARC PROTEIN, HUMAN;

ALLELISM; ARTICLE; BLOOD GROUP DUFFY SYSTEM; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE SEQUENCE; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEROTYPING; SINGLE NUCLEOTIDE POLYMORPHISM; ALGORITHM; ALLELE; DNA MICROARRAY; DNA SEQUENCE; GENETIC ASSOCIATION STUDY; GENETICS; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHASE TRANSITION;

ALGORITHMS; ALLELES; BASE SEQUENCE; DUFFY BLOOD-GROUP SYSTEM; GENETIC ASSOCIATION STUDIES; HUMANS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHASE TRANSITION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CELL SURFACE; SEQUENCE ANALYSIS, DNA;

EID: 84941599290     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12273     Document Type: Article

References (45)

1. Issitt PD, Anstee DJ: Applied Blood Group Serology, 4th edn. Durham, NC, Montgomery Scientific Publications, 1998
2. Reid ME, Lomas-Francis C, Olsson ML: The Blood Group Antigen Facts Book, 3rd edn. San Diego, CA, CA, Elsevier Academic Press, 2012
3. Daniels G: Human Blood Groups, 3rd edn. Oxford, Wiley-Blackwell Publishing, 2013
4. Iwamoto S, Omi T, Kajii E, et al.: Genomic organization of the glycoprotein D gene: Duffy blood group Fya/Fyb alloantigen system is associated with a polymorphism at the 44-amino acid residue. Blood 1995; 85:622-626
5. Mallinson G, Soo KS, Schall TJ, et al.: Mutations in the erythrocyte chemokine receptor (Duffy) gene: the molecular basis of the Fya/Fyb antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a-b-) phenotype. Br J Haematol 1995; 90:823-829
6. Tournamille C, Le Van Kim C, Gane P, et al.: Molecular basis and PCR-DNA typing of the Fya/fyb blood group polymorphism. Hum Genet 1995; 95:407-410
7. Chown B, Lewis M, Kaita H: The Duffy blood group system in Caucasians: evidence for a new allele. Am J Hum Genet 1965; 17:384-389
8. Lewis M, Kaita H, Chown B: The Duffy blood group system in Caucasians. A further population sample. Vox Sang 1972; 23:523-527
9. Tournamille C, Le Van Kim C, Gane P, et al.: Arg89Cys substitution results in very low membrane expression of the Duffy antigen/receptor for chemokines in Fy(x) individuals. Blood 1998; 92:2147-2156
10. Olsson ML, Smythe JS, Hansson C, et al.: The Fy(x) phenotype is associated with a missense mutation in the Fy(b) allele predicting Arg89Cys in the Duffy glycoprotein. Br J Haematol 1998; 103:1184-1191
11. Parasol N, Reid M, Rios M, et al.: A novel mutation in the coding sequence of the FY*B allele of the Duffy chemokine receptor gene is associated with an altered erythrocyte phenotype. Blood 1998; 92:2237-2243
12. Castilho L, Rios M, Pellegrino J Jr, et al.: A novel FY allele in Brazilians. Vox Sang 2004; 87:190-195
13. Yazdanbakhsh K, Rios M, Storry JR, et al.: Molecular mechanisms that lead to reduced expression of Duffy antigens. Transfusion 2000; 40:310-320
14. International Society for Blood Transfusion. Names for FY (ISBT 008) Blood Group Alleles: http://www.isbtweb.org/fileadmin/user_upload/WP_on_Red_Cell_Immunogenetics_and/Updates/008_FY_Alleles_v3_0_140328.pdf (Last accessed 23 August 2014).
15. Sanger R, Race RR, Jack J: The Duffy blood groups of New York negroes: the phenotype Fy (a-b-). Br J Haematol 1955; 1:370-374
16. Welch SG, McGregor IA, Williams K: The Duffy blood group and malaria prevalence in Gambian West Africans. Trans R Soc Trop Med Hyg 1977; 71:295-296
17. Olsson ML, Hansson C, Avent ND, et al.: A clinically applicable method for determining the three major alleles at the Duffy (FY) blood group locus using polymerase chain reaction with allele-specific primers. Transfusion 1998; 38:168-173
18. Tournamille C, Colin Y, Cartron JP, et al.: Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 1995; 10:224-228
19. Chaudhuri A, Polyakova J, Zbrzezna V, et al.: The coding sequence of Duffy blood group gene in humans and simians: restriction fragment length polymorphism, antibody and malarial parasite specificities, and expression in nonerythroid tissues in Duffy-negative individuals. Blood 1995; 85:615-621
20. Peiper SC, Wang ZX, Neote K, et al.: The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med 1995; 181:1311-1317
21. Iwamoto S, Li J, Omi T, et al.: Identification of a novel exon and spliced form of Duffy mRNA that is the predominant transcript in both erythroid and postcapillary venule endothelium. Blood 1996; 87:378-385
22. Oberdorfer CE, Kahn B, Moore V, et al.: A second example of anti-Fy3 in the Duffy blood group system. Transfusion 1974; 14:608-611
23. Kosinski KS, Molthan L, White L: Three examples of anti-Fy3 produced in Negroes. Rev Fr Transfus Immunohematol 1984; 27:619-624
24. Castilho L, Credidio DC, Ribeiro K, et al.: Anti-Fy3 in sickle cell disease patients genotyped as FY*B-33/FY*B-33. Transfusion 2009; 49(Suppl. 3):35A [S83-030K Abstract]
25. Rios M, Chaudhuri A, Mallinson G, et al.: New genotypes in Fy(a- b-) individuals: nonsense mutations (Trp to stop) in the coding sequence of either FY A or FY B. Br J Haematol 2000; 108:448-454
26. Albrey JA, Vincent EE, Hutchinson J, et al.: A new antibody, anti-Fy3, in the Duffy blood group system. Vox Sang 1971; 20:29-35
27. Tsuneyama H, Uchikawa M, Shinozaki K, et al.: A deletion in the Duffy gene of an apparently healthy individual with Fy(a-b-) phenotype. Transfusion 2000; 40(Suppl.):116S [SP301 Abstract]
28. Meyer S, Vollmert C, Trost N, et al.: High-throughput Kell, Kidd, and Duffy matrix-assisted laser desorption/ionization, time-of-flight mass spectrometry-based blood group genotyping of 4000 donors shows close to full concordance with serotyping and detects new alleles. Transfusion 2014; 54:3198-3207
29. Castilho L: The value of DNA analysis for antigens in the Duffy blood group system. Transfusion 2007; 47:28S-31S
30. McQuilten Z, Waters N, Polonsky M, et al.: Blood donation by African migrants and refugees in Australia: the role of demographic and socio-economic factors. Vox Sang 2014; 106:137-143
31. Montgomery J, Wittwer CT, Palais R, et al.: Simultaneous mutation scanning and genotyping by high-resolution DNA melting analysis. Nat Protoc 2007; 2:59-66
32. Lopez GH, McBean RS, Wilson B, et al.: Molecular typing for the Indian blood group associated 252G>C single nucleotide polymorphism in a selected cohort of Australian blood donors. Blood Transfus 2015; 13:78-85
33. Schmid P, Ravenell KR, Sheldon SL, et al.: DARC alleles and Duffy phenotypes in African Americans. Transfusion 2012; 52:1260-1267
34. Lopez GH, Condon JA, Wilson B, et al.: A novel FY*A allele with the 265T and 298A SNPs formerly associated exclusively with the FY*B allele and weak Fy(b) antigen expression: implication for genotyping interpretative algorithms. Vox Sang 2015; 108:52-57
35. Arndt PA, Garratty G, Horn T, et al.: New FY*01 Allele with weakened expression of Fya antigen. Transfusion 2013; 53(Suppl. 2):39A [S55-030I Abstract]
36. Seltsam A, Doescher A: Sequence-based typing of human blood groups. Transfus Med Hemother 2009; 36:204-212
37. Keller MA, Crowley JA, Horn T: Kidd antigen discrepancies: genotype-predicted phenotype vs serologic phenotype. Vox Sang 2014; 107(Suppl. 1):37 [4A-S25-02 Abstract]
38. Stabentheiner S, Danzer M, Niklas N, et al.: Overcoming methodical limits of standard RHD genotyping by next-generation sequencing. Vox Sang 2011; 100:381-388
39. Tilley L, Grimsley S: Is next generation sequencing the future of blood group testing? Transfus Apher Sci 2014; 50:183-188
40. Liu Z, Liu M, Mercado T, et al.: Extended blood group molecular typing and next-generation sequencing. Transfus Med Rev 2014; 28:177-186
41. Fichou Y, Le Marechal C, Jamet D, et al.: Establishment of a medium-throughput approach for the genotyping of RHD variants and report of nine novel rare alleles. Transfusion 2013; 53:1821-1828
42. Avent ND, Madgett TE, Halawani AJ, et al.: Next Generation Sequencing: academic overkill or high-resolution blood group genotyping?. Vox Sang 2014; 107(Suppl. 1):37 [4A-S25-01 Abstract]
43. Altayar MA, Halawani AJ, Kiernan M, et al.: Extensive genotyping of blood groups Duffy, Kidd and ABO by Next Generation Sequencing. Vox Sang 2014; 107(Suppl. 1):187 [P-407 Abstract]
44. Halawani AJ, Altayar MA, Kiernan M, et al.: Can Next-Generation DNA sequencing solve the Rh complexity for genotyping? Vox Sang 2014; 107(Suppl. 1):196 [P-440 Abstract]
45. Peyrard T: Molecular tools for investigating Immunohematology problems. Vox Sang 2014; 107(Suppl. 1):3 [1B-A03-2 Abstract]